ABSTRACT
BACKGROUND AND PURPOSE: Prostanoid EP(4) receptor antagonists may have therapeutic utility in the treatment of migraine since EP(4) receptors have been shown to be involved in prostaglandin (PG)E(2)-induced cerebral vascular dilatation, which may be an important contributor to migraine pain. This study reports the pharmacological characterization of BGC20-1531, a novel EP(4) receptor antagonist. EXPERIMENTAL APPROACH: BGC20-1531 was characterized in radioligand binding and in vitro functional assays employing recombinant and native EP(4) receptors. Changes in canine carotid haemodynamics were used to assess the pharmacodynamic profile of BGC20-1531 in vivo. KEY RESULTS: BGC20-1531 exhibited high affinity at recombinant human EP(4) receptors expressed in cell lines (pK(B) 7.6) and native EP(4) receptors in human cerebral and meningeal artery (pK(B) 7.6-7.8) but showed no appreciable affinity at a wide range of other receptors (including other prostanoid receptors), channels, transporters and enzymes (pKi < 5). BGC20-1531 competitively antagonized PGE(2)-induced vasodilatation of human middle cerebral (pK(B) 7.8) and meningeal (pK(B) 7.6) arteries in vitro, but had no effect on responses induced by PGE(2) on coronary, pulmonary or renal arteries in vitro. BGC20-1531 (1-10 mg.kg(-1) i.v.) caused a dose-dependent antagonism of the PGE(2)-induced increase in canine carotid blood flow in vivo. CONCLUSIONS AND IMPLICATIONS: BGC20-1531 is a potent and selective antagonist at EP(4) receptors in vitro and in vivo, with the potential to alleviate the symptoms of migraine that result from cerebral vasodilatation. BGC20-1531 is currently in clinical development for the treatment of migraine headache.
Subject(s)
Migraine Disorders/drug therapy , Pyridines/pharmacology , Receptors, Prostaglandin E/antagonists & inhibitors , Sulfonamides/pharmacology , Vasodilator Agents/pharmacology , Adult , Aged , Animals , Carotid Artery, Common/drug effects , Carotid Artery, Common/physiology , Cell Line , Cerebral Arteries/drug effects , Cerebral Arteries/physiology , Dinoprostone/pharmacology , Dogs , Dose-Response Relationship, Drug , Female , Humans , In Vitro Techniques , Male , Meningeal Arteries/drug effects , Meningeal Arteries/physiology , Middle Aged , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/physiology , Pyridines/adverse effects , Pyridines/therapeutic use , Radioligand Assay , Receptors, Prostaglandin E, EP4 Subtype , Recombinant Proteins/antagonists & inhibitors , Sulfonamides/adverse effects , Sulfonamides/therapeutic use , Vasoconstriction/drug effects , Vasodilator Agents/adverse effects , Vasodilator Agents/therapeutic use , Young AdultABSTRACT
The synthesis and biological activity of a new series of benzamides and related compounds that upregulate the expression of the low-density lipoprotein (LDL) receptor in human hepatocytes (HepG2 cells) by a novel mechanism are described. The lead compound, N-[5-[(3-cyclohexylpropionyl)amino]-2-methylphenyl]-4-hydroxybe nzamide (1, RPR102359), increased the expression of the LDL receptors in HepG2 cells by 80% when tested at a concentration of 3 microM. Mevinolin (lovastatin) was found to increase the LDL receptor expression by 70% at the same concentration. In contrast to mevinolin, 1 was found to have no effect on cholesterol biosynthesis in liver homogenates or in HepG2 cells at doses where substantial upregulation of the LDL receptor was observed and thus stimulated LDL receptor expression by a novel mechanism.
Subject(s)
Benzamides/chemical synthesis , Benzamides/pharmacology , Liver/metabolism , Parabens/chemical synthesis , Parabens/pharmacology , Phenylenediamines/chemical synthesis , Phenylenediamines/pharmacology , Receptors, LDL/biosynthesis , Transcription, Genetic/drug effects , Benzamides/chemistry , Carcinoma, Hepatocellular , Cell Line , Cholesterol/biosynthesis , Humans , Indicators and Reagents , Liver/drug effects , Liver Neoplasms , Lovastatin/pharmacology , Magnetic Resonance Spectroscopy , Models, Molecular , Molecular Structure , Parabens/chemistry , Phenylenediamines/chemistry , Structure-Activity Relationship , Tumor Cells, Cultured , Up-Regulation/drug effectsABSTRACT
We have investigated the growth promoting activities of two potent vasoactive substances, serotonin and angiotensin II (AII), on cultured porcine aortic smooth muscle cells (ASMC), using a defined serum-free medium. Serotonin (30 nM to 30 microM) stimulated ASMC DNA synthesis both alone and in combination with platelet-derived growth factor (PDGF) and epidermal growth factor (EGF). Serotonin-induced DNA synthesis was significantly inhibited by ketanserin (5-hydroxytryptamine-2 (5HT-2) receptor antagonist). AII (3-10 nM) failed to stimulate ASMC DNA synthesis directly, either alone or in combination with PDGF or EGF. Since both serotonin and AII were found to activate phosphatidylinositol turnover and are reported to mobilise intracellular calcium, it is apparent that these events alone are insufficient to stimulate ASMC mitogenesis.
Subject(s)
Angiotensin II/pharmacology , Muscle, Smooth, Vascular/cytology , Serotonin/pharmacology , Animals , Aorta, Thoracic , Cell Division/drug effects , Cells, Cultured , DNA/biosynthesis , Epidermal Growth Factor/pharmacology , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/metabolism , Phosphatidylinositols/metabolism , Platelet-Derived Growth Factor/pharmacology , SwineABSTRACT
N-Formyl dipeptide conjugates of ampicillin and amoxicillin related to the chemotactic peptide N-formyl-L-methionyl-L-leucyl-L-phenylalanine were synthesized and assessed for antibacterial activity and affinity for the chemotactic peptide receptor of differentiated human promyelocytic leukemia (HL-60) cells. The conjugates and parent beta-lactam antibiotics showed similar antibacterial activities against Escherichia coli and Staphylococcus aureus. The affinity of each conjugate for the chemotactic peptide receptor was determined in a competitive binding assay, using 3H-labeled N-formyl-L-methionyl-L-leucyl-L-phenylalanine. All conjugates bound to the receptor, but with affinities ranging from 1/3 to 1/100 that of the tritiated substrate. There was good correlation between receptor affinity and stimulation of chemotaxis. The peptide-antibiotic conjugates also stimulated the oxidative metabolism of the HL-60 cells by inducing the production of superoxide and hydrogen peroxide as determined by Luminol- and Lucigenin-enhanced chemiluminescence. These conjugates, based on N-formyl-L-methionyl-L-leucyl-L-phenylalanine, thus combine both potent antibacterial and immunostimulatory properties within the same molecule.
Subject(s)
Adjuvants, Immunologic , Amoxicillin/analogs & derivatives , Ampicillin/analogs & derivatives , Bacteria/drug effects , N-Formylmethionine Leucyl-Phenylalanine/analogs & derivatives , Amoxicillin/pharmacology , Ampicillin/pharmacology , Cell Differentiation/drug effects , Cell Line , Chemotaxis/drug effects , Dimethyl Sulfoxide/pharmacology , Humans , Hydrogen Peroxide/pharmacology , Luminescent Measurements , Microbial Sensitivity Tests , N-Formylmethionine Leucyl-Phenylalanine/metabolism , N-Formylmethionine Leucyl-Phenylalanine/pharmacology , Oxygen Consumption/drug effects , Superoxides/metabolismABSTRACT
Diastereoisomers of 3,17 beta-dihydroxy-20,21-epoxy-19-norpregna-1,3,5(10)-triene have been prepared as potential antitumor agents. Both isomers undergo the base-catalyzed Payne rearrangement. The isomers were cytotoxic to mammalian cells in culture and were able to displace [3H]estradiol from binding sites in rat uterine cytosols with 1/7 and 1/70 the potency of estradiol. The reasons for this difference are discussed.
Subject(s)
Antineoplastic Agents/chemical synthesis , Norpregnatrienes/chemical synthesis , Receptors, Estrogen/metabolism , Animals , Antineoplastic Agents/metabolism , Cell Survival/drug effects , Estradiol/metabolism , Female , Norpregnatrienes/metabolism , Norpregnatrienes/pharmacology , Rats , Stereoisomerism , Structure-Activity Relationship , Uterus/drug effects , Uterus/metabolismABSTRACT
Several estrogen derivatives containing the alpha-methylene-delta-lactone group as part of the D-ring were prepared as anti-tumor agents. The compounds were highly toxic towards HeLa S3 cells grown in culture.